AP-HP Centre, DMU Psychiatrie et Addictologie, Corentin Celton Hospital, Issy-les-Moulineaux, France.
Campus de Somosaguas, Universidad Complutense de Madrid, Pozuelo de Alarcón, Spain.
J Travel Med. 2022 May 31;29(3). doi: 10.1093/jtm/taab195.
In this multicenter retrospective observational study involving 58 562 adult patients hospitalized for COVID-19, melatonin use ( = 272) at a mean daily dose of 2.6 mg was not associated with reduced mortality.
在这项涉及 58562 名因 COVID-19 住院的成年患者的多中心回顾性观察研究中,使用平均日剂量为 2.6 毫克的褪黑素( = 272)与降低死亡率无关。